GlassScriptPhysician profile
Steven Finkelstein
NPI 1700078409
$578,031.73
in general payments reported to CMS, 2019-2025
93 companies · $113K in 2025
The $113K reported for 2025 was more than what 99% of Radiation Oncology providers received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90K · 2020: $76K · 2021: $95K · 2022: $83K · 2023: $63K · 2024: $58K · 2025: $113K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $118K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $69K · Honoraria: $25K · Travel and Lodging: $13K · Food and Beverage: $9,825.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $118,254.37 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $68,509.24 |
| Honoraria | $24,700.00 |
| Travel and Lodging | $13,106.26 |
| Food and Beverage | $9,825.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Progenics Pharmaceuticals, INC. | $145,543.78 | 2021-2025 | Pylarify |
| Bayer Healthcare Pharmaceuticals INC. | $138,875.76 | 2019-2025 | |
| Janssen Biotech, INC. | $71,752.81 | 2019-2025 | Erleada, Carvykti, Rybrevant |
| Novartis Pharmaceuticals Corporation | $37,977.52 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $31,126.60 | 2019-2025 | Imfinzi, Lynparza, Enhertu |
| Astellas Pharma US INC | $28,387.67 | 2019-2025 | Xtandi, Xospata, Padcev |
| Blue Earth Diagnostics | $26,293.31 | 2020-2025 | Posluma |
| Bioprotect Medical, INC. | $25,018.86 | 2024-2025 | Bioprotect Balloon Implant System |
| Tolmar, INC. | $15,240.00 | 2023-2024 | |
| Pfizer INC. | $11,199.58 | 2019-2025 | |
| Sumitomo Pharma America, INC. | $10,912.33 | 2023-2025 | Orgovyx |
| Boston Scientific Corporation | $9,885.51 | 2019-2025 | Spaceoar Vue System - 10ml |
| Janssen Scientific Affairs, LLC | $4,076.30 | 2019 | |
| Novocure INC. | $2,748.17 | 2020-2022 | |
| Amgen INC. | $2,534.04 | 2019-2023 | Xgeva, Nplate, Vectibix |
Show all 93 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myovant Sciences INC. | $2,237.67 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $1,928.49 | 2019-2024 | Opdivo |
| Janssen Global Services, LLC | $1,755.00 | 2022 | |
| Taiho Oncology, INC. | $1,743.22 | 2020-2021 | |
| Regeneron Healthcare Solutions, INC. | $850.28 | 2019-2024 | Libtayo |
| Elekta, INC. | $580.33 | 2020-2021 | |
| Siemens Medical Solutions USA, INC. | $506.38 | 2024-2025 | Somatom Go.Top, Varian Ethos Treatment Planning, Clinac Ix |
| Daiichi Sankyo INC. | $505.05 | 2019-2024 | Enhertu |
| Eisai INC. | $409.36 | 2019-2024 | |
| Athenex Pharmaceutical Division, LLC | $376.02 | 2019 | |
| Ferring Pharmaceuticals INC. | $355.53 | 2024-2025 | Adstiladrin |
| Genzyme Corporation | $339.75 | 2021-2024 | |
| Octapharma USA, INC. | $304.15 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $275.91 | 2019-2024 | Keytruda, Lynparza |
| Dendreon Pharmaceuticals LLC | $274.35 | 2019-2025 | Provenge |
| Lilly USA, LLC | $196.78 | 2019-2024 | Jaypirca, Verzenio, Retevmo |
| Myriad Genetic Laboratories, INC. | $190.55 | 2024-2025 | Prolaris |
| Beigene USA, INC. | $181.11 | 2020-2024 | Brukinsa |
| Foundation Medicine, INC. | $170.08 | 2019-2020 | |
| Telix Pharmaceuticals | $151.08 | 2024-2025 | Illuccix |
| Abbvie INC. | $149.51 | 2019-2025 | |
| Incyte Corporation | $147.60 | 2020-2024 | Monjuvi, Pemazyre, Jakafi |
| Histosonics, INC. | $142.42 | 2025 | |
| Teleflex LLC | $138.19 | 2025 | Barrigel |
| Janssen Pharmaceuticals, INC | $132.52 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $131.63 | 2019-2024 | Ninlaro |
| Celgene Corporation | $104.48 | 2019-2022 | |
| Pharmacosmos Therapeutics INC. | $101.38 | 2022-2023 | Monoferric |
| Coherus Oncology, INC. | $93.21 | 2020-2024 | |
| Genentech USA, INC. | $89.27 | 2019-2023 | Columvi, Lunsumio, Polivy |
| Boehringer Ingelheim Pharmaceuticals, INC. | $88.49 | 2019-2022 | |
| Seagen INC. | $84.36 | 2022-2023 | Padcev, Adcetris, Tivdak |
| Blueprint Medicines Corporation | $82.68 | 2020-2023 | Ayvakit |
| Accord Healthcare, INC. | $81.58 | 2025 | |
| Csl Behring | $81.02 | 2023-2024 | Afstyla, Idelvion |
| Glaxosmithkline, LLC. | $79.33 | 2020-2024 | Zejula, Jemperli, Ojjaara |
| G1 Therapeutics, INC. | $77.00 | 2022-2023 | Cosela |
| Immunitybio, INC. | $73.66 | 2025 | |
| Springworks Therapeutics, INC. | $71.19 | 2024-2025 | Ogsiveo |
| Ipsen Biopharmaceuticals, INC | $70.49 | 2021-2024 | Onivyde, Somatuline Depot |
| Exelixis INC. | $69.95 | 2019-2023 | Cabometyx |
| Jazz Pharmaceuticals INC. | $69.64 | 2020-2024 | Zepzelca |
| Aveo Pharmaceuticals, INC. | $62.73 | 2021-2023 | Fotivda |
| Alexion Pharmaceuticals, INC. | $58.75 | 2023-2024 | Ultomiris |
| Karyopharm Therapeutics INC. | $52.41 | 2023 | Xpovio |
| Rigel Pharmaceuticals, INC. | $49.60 | 2020-2023 | Rezlidhia, Tavalisse |
| Mirati Therapeutics, INC. | $49.49 | 2023-2024 | Krazati |
| Apellis Pharmaceuticals, INC. | $47.44 | 2023-2024 | Empaveli |
| Sun Pharmaceutical Industries INC. | $45.25 | 2023-2025 | Yonsa, Odomzo |
| Emd Serono, INC. | $41.00 | 2021-2022 | |
| Acceleron Pharma, INC. | $37.44 | 2021 | |
| Pharmacyclics LLC, An Abbvie Company | $35.45 | 2020-2022 | |
| Varian Medical Systems, INC. | $33.34 | 2020 | |
| Astellas Pharma Global Development | $28.98 | 2025 | Padcev |
| Eusa Pharma (US) LLC | $28.79 | 2022 | |
| Global Blood Therapeutics, INC. | $26.60 | 2020-2022 | |
| Tersera Therapeutics LLC | $25.92 | 2021 | |
| Kite Pharma, INC. | $22.74 | 2021 | |
| Stemline Therapeutics INC. | $22.38 | 2023 | Orserdu |
| Array Biopharma INC | $21.08 | 2023 | Mektovi, Xalkori, Braftovi |
| Puma Biotechnology, INC. | $19.93 | 2023 | Nerlynx |
| Medtronic, INC. | $19.84 | 2025 | Altaviva |
| Deciphera Pharmaceuticals INC. | $18.57 | 2021 | |
| Sobi, INC | $18.29 | 2023 | |
| Genmab U.S., INC. | $18.11 | 2023 | Epkinly |
| Bayer Healthcare LLC | $17.27 | 2025 | |
| Spectrum Pharmaceuticals INC. | $16.94 | 2023 | Rolvedon |
| Adc Therapeutics America, INC. | $16.81 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $15.44 | 2020 | |
| Helsinn Therapeutics (U.S.), INC. | $15.12 | 2021 | |
| Immunocore Limited | $14.52 | 2024 | Kimmtrak |
| Coloplast Corp | $14.46 | 2024 | |
| Tesaro, INC. | $13.66 | 2019 | |
| Kyowa Kirin, INC. | $13.54 | 2023 | Poteligeo |
| Servier Pharmaceuticals LLC | $12.90 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $11.90 | 2019 | |
| Emmaus Medical, INC. | $11.54 | 2020 | |
| Clovis Oncology, INC. | $10.57 | 2019 |
Drugs and devices associated with these payments
Pylarify $97KBioprotect Balloon Implant System $25KPluvicto $18KEligard $13KNubeqa $12KOrgovyx $11KImfinzi $11KPosluma $8,521Xofigo $4,055Xtandi $1,724Erleada $1,151Talzenna $386Adstiladrin $356Libtayo $348Illuccix $302Provenge $238Kisqali $195Prolaris $191Enhertu $156Sarclisa $150Barrigel $138Axumin $134Somatom Go.Top $125Rybrevant $125Carvykti $125Scemblix $119Verzenio $113Jaypirca $113Lynparza $113Varian Ethos Treatment Planning $112Brukinsa $104Ninlaro $99.60Clinac Ix $95.12Padcev $92.96Keytruda $85.90Fabhalta $83.36Camcevi $81.58Idelvion $81.02Afstyla $81.02Monoferric $77.05Tasigna $76.12Piqray $74.27Anktiva $73.66Lutathera $73.45Ogsiveo $71.19Opdivo $66.15Lenvima $65.12Ultomiris $58.75Promacta $56.44Monjuvi $56.34Elahere $56.17Xpovio $52.41Mekinist $52.06Zepzelca $49.71Krazati $49.49Empaveli $47.44Yonsa $45.25Retevmo $37.98Spaceoar Vue System - 10ml $37.65Xgeva $37.53Vectibix $37.53Nplate $37.53Pemazyre $37.18Xospata $37.02Oxbryta $36.82Jemperli $36.62Zejula $36.62Jakafi $33.81Somatuline Depot $29.90Onivyde $29.90Balversa $29.88Akeega $29.88Kyprolis $29.39Udenyca $24.33Elitek $22.89Jevtana $22.60Venclexta $22.55Orserdu $22.38Odomzo $21.20Mektovi $21.08Xalkori $21.08Braftovi $21.08Lorbrena $21.08Nerlynx $19.93Altaviva $19.84Tavalisse $19.49Rezlidhia $19.49Cosela $19.44Adcetris $19.22Zynyz $18.93Doptelet $18.29Epkinly $18.11Vitrakvi $18.09Stivarga $18.09Cabometyx $17.84Columvi $17.28Lunsumio $17.28Polivy $17.28Ojjaara $17.20Rolvedon $16.94
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Finkelstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.